US Stock MarketDetailed Quotes

BIVI BioVie

Watchlist

0.386
-0.027-6.52%

Close Jul 19 16:00 ET

0.385
-0.001-0.13%

Post 19:16 ET

23.58MMarket Cap-414P/E (TTM)

BioVie Stock Forum

Trytosaveabit

Jun 21 08:08

Watching! Food for thought.

$BioVie(BIVI.US)$ $Mobilicom(MOB.US)$ Sometimes a ticker will get a decent boost from appearances on broadcasts like this one! (((((. ORLANDO, FL / ACCESSWIRE / June 21, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Mobilicom Ltd. (Nasdaq:MOB) on the RedChip Small Stocks, Big Moneyshow, a sponsored program on Bloomberg TV, this Saturday, June 22, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes ...

MessaMel

Jun 5 22:47

Momentum tickers: Should still be slow paced(these are on the scanners)
BIVI(.49) I think has bottomed at .42 - Good adds here at .40s for a run to $1. Has a large gap to $1.76 which is high target. Can use the .42 as a safety for stop loss
BIOR(.70) Filed for mixed shelf offering two weeks ago, been trying to find these…HC Wainwright has $15 Target on it, don’t believe it but I do like it for gap fill to 1.08 minimum. I think this is going to get ran up and offering dropped. Should get dips t...

Jaguar8

May 22 08:46

$BioVie(BIVI.US)$
NEWS
BioVie’s Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson’s Disease Patients
BioVie announced promising results from a Phase 2a trial of their drug bezisterim for Parkinson's disease. Data presented at the XXIX World Congress on Parkinson's Disease and Related Disorders showed that patients treated with bezisterim in combination with levodopa/carbidopa experienced significant improvements in both motor and non-motor s...

Trytosaveabit

Apr 29 07:00

News

$BioVie(BIVI.US)$ BioVie Awarded up to $13.1 Million in Funding From U.S. Department of Defense to Evaluate Bezisterim (Ne3107) for the Treatment of Long Covid

NANA7687

Apr 24 14:44

Maybe 0.6 at the end?

$BioVie(BIVI.US)$

Jaguar8

Apr 18 07:21

$BioVie(BIVI.US)$
NEWS
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary BioVie Inc. (Nasdaq: BIVI) announced the approval of the non-proprietary name 'bezisterim' for NE3107, a potential treatment for neurological disorders. The company will present data at the 12th Annual Alzheimer's & Parkinson's Drug Development S...

Golden Government _1

Apr 12 08:43

$BioVie(BIVI.US)$ BIV201 Phase 3 is pending funds from “undisclosed yet partner” , partner is dragging their feet and not in a hurry to cut the check due economy , covid and ukraine bull. Especially if that undisclosed yet partner is looking to buy out Biovie , thus intrested to buy BIVI shares at cheap.
The good news will be in “middle of summer 2024” or earlier , when partnership and BIV201 Phase 3 funding will be announced

Powdahound

Apr 11 22:00

$BioVie(BIVI.US)$ 🔥🔥🔥🔥🔥🔥

Becky007

Apr 3 11:46

$BioVie(BIVI.US)$ Holding @ 1.3. When is the next PR? Its in pathetic state seriously….

Dragana

Mar 6 16:01

$BioVie(BIVI.US)$ BUG BIG news, there finished the second stage of testing(which worked) for a new drug that helps with Parkinson's and dementia, they have 1 more test and if it works they will go NUCLEAR!!! ☘️💪🔥😇🙏

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall